IT202100024596A1 - Composition of ointment or cream based on olive oil, and its uses in the field of pain relief - Google Patents
Composition of ointment or cream based on olive oil, and its uses in the field of pain relief Download PDFInfo
- Publication number
- IT202100024596A1 IT202100024596A1 IT102021000024596A IT202100024596A IT202100024596A1 IT 202100024596 A1 IT202100024596 A1 IT 202100024596A1 IT 102021000024596 A IT102021000024596 A IT 102021000024596A IT 202100024596 A IT202100024596 A IT 202100024596A IT 202100024596 A1 IT202100024596 A1 IT 202100024596A1
- Authority
- IT
- Italy
- Prior art keywords
- composition
- olive oil
- ointment
- percentage
- oil
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 20
- 239000004006 olive oil Substances 0.000 title claims description 16
- 235000008390 olive oil Nutrition 0.000 title claims description 16
- 239000002674 ointment Substances 0.000 title claims description 11
- 239000006071 cream Substances 0.000 title claims description 10
- 208000002193 Pain Diseases 0.000 title claims description 9
- 230000036407 pain Effects 0.000 title claims description 8
- 235000005979 Citrus limon Nutrition 0.000 claims description 10
- 244000131522 Citrus pyriformis Species 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims 3
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Anesthesiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
Description
Composizione di unguento o crema a base di olio di oliva, e suoi usi in campo antidolorifico Composition of ointment or cream based on olive oil, and its uses in the field of pain relief
La presente invenzione concerne una composizione di unguento o crema a base di olio di oliva e suoi usi in campo antidolorifico. In particolare, l?invenzione concerne una composizione di unguento a base di olio di oliva da utilizzare nel trattamento di dolori muscolari, infiammazioni come, ad esempio, gli arrossamenti, emorroidi, piaghe da decubito, infiammazioni della pelle, ecc. The present invention relates to an ointment or cream composition based on olive oil and its uses in the pain-relieving field. In particular, the invention relates to an ointment composition based on olive oil to be used in the treatment of muscular pains, inflammations such as, for example, redness, hemorrhoids, bedsores, skin inflammations, etc.
La presente invenzione viene impiegata per il trattamento di stati dolorifici e pu? essere classificata tra gli unguenti o creme che hanno la propriet? di attenuare il dolore. The present invention is used for the treatment of pain states and can be classified among the ointments or creams that have the property? to ease the pain.
Tra i prodotti impiegati nel trattamento degli stati dolorifici come, ad esempio, ustioni, arrossamenti, emorroidi, piaghe da decubito, infiammazioni della pelle, si utilizzano spesso prodotti a base di cortisone o antistaminici, anche associati ad antibiotici. Tuttavia, i prodotti a base di cortisone non possono essere impiegati per lunghi periodi poich? la loro efficacia diminuisce nel tempo. Among the products used in the treatment of pain states such as, for example, burns, redness, hemorrhoids, bedsores, inflammation of the skin, products based on cortisone or antihistamines are often used, also associated with antibiotics. However, cortisone-based products cannot be used for long periods as they their effectiveness decreases over time.
Inoltre, quando il trattamento con cortisonici viene interrotto, spesso la lesione riappare. Also, when corticosteroid treatment is stopped, the lesion often reappears.
Altri tipi di prodotti quali ad esempio i cicatrizzanti o gli antibiotici possono invece ingenerare reazioni allergiche. Other types of products such as healing agents or antibiotics can instead generate allergic reactions.
Inoltre, la composizione ? esclusivamente di origine naturale e senza controindicazioni, quindi indicata anche per un vasto utilizzo, ossia dall?adulto al bambino senza controindicazioni ed anche per animali. Also, the composition? exclusively of natural origin and without contraindications, therefore also indicated for a wide use, i.e. from adults to children without contraindications and also for animals.
I singoli ingredienti, seppur dotati di propriet? lenitive, lubrificanti e antisettiche, da soli non riescono a dare il risultato evidente che invece si ottiene con la loro miscelazione, nel giusto dosaggio e lavorazione di componenti. The individual ingredients, albeit with properties? soothing, lubricating and antiseptic, by themselves they cannot give the clear result that is instead obtained by mixing them, in the right dosage and processing of components.
Infatti, l'olio di oliva, grazie alla presenza nella sua composizione di acidi grassi, vitamine e minerali, funge da lenitore di arrossamenti della pelle, irritazioni, screpolature e desquamazioni. In fact, olive oil, thanks to the presence of fatty acids, vitamins and minerals in its composition, acts as a soothing agent for skin redness, irritation, cracking and flaking.
L?olio essenziale di limone ha propriet? calmanti, antisettiche: ? un eccellente antibiotico, le propriet? antibiotiche ed emostatiche si rivelano utili in caso di ferite infette, infezioni dei tessuti, stomatiti, afte, herpes labiale, gengive infiammate o che sanguinano, tonificanti del sistema circolatorio: stimola la circolazione linfatica e venosa, rafforza i vasi sanguigni e fluidifica il sangue, antinfiammatorie: l'olio essenziale di limone possiede propriet? antiflogistiche in caso di artrite e reumatismi. Lemon essential oil has properties calming, antiseptic: ? an excellent antibiotic, the properties? antibiotics and haemostatics are useful in case of infected wounds, tissue infections, stomatitis, mouth ulcers, cold sores, inflamed or bleeding gums, toning the circulatory system: stimulates lymphatic and venous circulation, strengthens blood vessels and thins the blood, anti-inflammatory: lemon essential oil has properties antiphlogistic in case of arthritis and rheumatism.
Forma pertanto oggetto specifico della presente invenzione una composizione di unguento topica comprendente o consistente in olio di oliva e olio essenziale di limone ed eventualmente uno o pi? eccipienti e/o coadiuvanti farmaceuticamente accettabili. La composizione pu? essere formulata in forma di unguento o crema. Therefore, a specific object of the present invention is a topical ointment composition comprising or consisting of olive oil and lemon essential oil and optionally one or more? pharmaceutically acceptable excipients and/or adjuvants. The composition can be formulated in the form of an ointment or cream.
La percentuale in peso di olio di oliva nella miscela pu? variare da 80 a 20% in peso rispetto al peso della miscela, preferibilmente da 70 a 30%, ancora pi? preferibilmente da 60 a 40%. The percentage by weight of olive oil in the blend can vary from 80 to 20% by weight with respect to the weight of the mixture, preferably from 70 to 30%, even more? preferably from 60 to 40%.
Costituisce ulteriore oggetto della presente invenzione l?impiego della composizione come definita sopra nel trattamento di stati dolorifici provocati da arrossamenti, emorroidi, piaghe da decubito, infiammazioni della pelle, eritemi solari e arrossamenti da pannolino, dolori muscolari, dolori reumatici ecc. A further object of the present invention is the use of the composition as defined above in the treatment of painful states caused by redness, hemorrhoids, bedsores, inflammation of the skin, sunburn and nappy rash, muscle pain, rheumatic pain, etc.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000024596A IT202100024596A1 (en) | 2021-09-24 | 2021-09-24 | Composition of ointment or cream based on olive oil, and its uses in the field of pain relief |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000024596A IT202100024596A1 (en) | 2021-09-24 | 2021-09-24 | Composition of ointment or cream based on olive oil, and its uses in the field of pain relief |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202100024596A1 true IT202100024596A1 (en) | 2023-03-24 |
Family
ID=79601493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102021000024596A IT202100024596A1 (en) | 2021-09-24 | 2021-09-24 | Composition of ointment or cream based on olive oil, and its uses in the field of pain relief |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202100024596A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9408877B1 (en) * | 2013-04-12 | 2016-08-09 | Marcia Patricia Cox | Compositions and process for skin restoration |
CN107519043A (en) * | 2016-06-21 | 2017-12-29 | 无锡伟通商标代理服务有限公司 | A kind of lemon makeup remover and preparation method thereof |
WO2021159155A1 (en) * | 2020-02-12 | 2021-08-19 | Bentsen Paal | Composition |
-
2021
- 2021-09-24 IT IT102021000024596A patent/IT202100024596A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9408877B1 (en) * | 2013-04-12 | 2016-08-09 | Marcia Patricia Cox | Compositions and process for skin restoration |
CN107519043A (en) * | 2016-06-21 | 2017-12-29 | 无锡伟通商标代理服务有限公司 | A kind of lemon makeup remover and preparation method thereof |
WO2021159155A1 (en) * | 2020-02-12 | 2021-08-19 | Bentsen Paal | Composition |
Non-Patent Citations (6)
Title |
---|
ANONYMOUS: "Olio d'oliva e succo di limone, elisir di lunga vita", 22 April 2020 (2020-04-22), XP055915048, Retrieved from the Internet <URL:https://www.badevisco.com/olio-oliva-succo-limone-elisir-lunga-vita/> [retrieved on 20220425] * |
DATABASE GNPD [online] MINTEL; 12 February 2018 (2018-02-12), ANONYMOUS: "Active Hemp Ointment", XP055773170, retrieved from https://www.gnpd.com/sinatra/recordpage/5410087/ Database accession no. 5410087 * |
DATABASE GNPD [online] MINTEL; 17 August 2021 (2021-08-17), ANONYMOUS: "Zingy Lemon Salad Dressing Spray", XP055915038, retrieved from https://www.gnpd.com/sinatra/recordpage/8939923/ Database accession no. 8939923 * |
DATABASE GNPD [online] MINTEL; 20 August 2021 (2021-08-20), ANONYMOUS: "Lemon Spread", XP055915044, retrieved from https://www.gnpd.com/sinatra/recordpage/8951320/ Database accession no. 8951320 * |
DATABASE GNPD [online] MINTEL; 24 April 2020 (2020-04-24), ANONYMOUS: "Extra Virgin Olive Oil and Lemon Seasoning", XP055915045, retrieved from https://www.gnpd.com/sinatra/recordpage/7571679/ Database accession no. 7571679 * |
PUERTA DE LA R ET AL: "EFFECT OF MINOR COMPONENTS OF VIRGIN OLIVE OIL IN TOPICAL ANTIINFLAMMATORY ASSAYS", ZEITSCHRIFT FUER NATURFORSCHUNG. C, A JOURNAL OF BIOSCIENCES, VERL. D. ZEITSCHRIFT FÜR NATURFORSCHUNG, DE, vol. 55, no. 9/10, 1 September 2000 (2000-09-01), pages 814 - 819, XP009013930, ISSN: 0939-5075 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AkhavanKarbassi et al. | Randomized doubleblind placebocontrolled trial of propolis for oral mucositis in patients receiving chemotherapy for head and neck cancer | |
US5399349A (en) | Treatment of acne | |
JP2022546928A (en) | TOPICAL FORMULATIONS CONTAINING CANNABIDIOL, METHODS FOR PREPARATION OF COMPOSITIONS AND USES THEREOF | |
AU2310200A (en) | Pharmaceutical compositions | |
US8846646B2 (en) | Topical treatment of skin infection | |
ES2635169T3 (en) | Tamarind seed polysaccharide and Ferula hermonis extract for use in the treatment of inflammatory diseases | |
US20030194446A1 (en) | Zinc oxide compositions for dermatheraputics | |
CA2408541C (en) | Treating eczema and/or psoriasis | |
IT202100024596A1 (en) | Composition of ointment or cream based on olive oil, and its uses in the field of pain relief | |
ITMI981073A1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SKIN DISEASES ON AN IMMUNE OR PROLIFERATIVE INFLAMMATORY BASIS | |
US20130237600A1 (en) | Treating eczema and/or psoriasis | |
ES2221928T3 (en) | POMADAS THAT INCLUDE MOMETASONE FUROATE AND SALICILIC ACID FOR THE TOPICAL TREATMENT OF PSORIASIS. | |
Semkina | Ointments, gels, liniments, and creams containing phytopreparations (a review) | |
August | Cutaneous necrosis due to cetrimide application. | |
US8900601B2 (en) | Permeable mixtures, methods and compositions for the skin | |
LeVan et al. | The use of silicones in dermatology | |
DE3688787D1 (en) | PRODUCTION OF A MEDICINE AGAINST ARTHRITIS AND RHEUMATISM. | |
CA2840918C (en) | Topical compositions for use in the prevention and/or treatment of dermatitis | |
JPH01294635A (en) | Pharmaceutical composition for local administration | |
EP1048294A2 (en) | Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain | |
Sabry | A three-stage strategy in treating acne vulgaris in patients with atopic dermatitis-a pilot study | |
WO2023168004A1 (en) | Topical formulation to decrease skin inflammation or redness | |
EP3949980A1 (en) | Compositions for the treatment of atopic dermatitis containing ozonated oils and natural antioxidant agents | |
Litt | Alternative topical therapy | |
GR1009906B (en) | Paste for the prevention and therapy of bedsores and decubitus ulcers - production method thereof |